aim
studi
herp
simplex
virus
import
pathogen
human
discoveri
novel
antihsv
drug
low
toxic
deserv
great
effort
rhubarb
one
oldest
bestknown
tradit
chines
medicin
initi
studi
test
emodin
activ
ingredi
rheum
tanguticum
r
tanguticum
one
chines
rhubarb
hsv
infect
investig
antivir
activ
hsv
infect
tissu
cultur
cell
mous
model
materi
method
emodin
extract
purifi
r
tanguticum
cultiv
high
mountain
area
qinghai
puriti
determin
high
perform
liquid
chromatographi
antivir
experi
emodin
hsv
infect
perform
vitro
vivo
vivo
hsvinfect
mice
oral
administ
emodin
begin
h
posthsv
exposur
dosag
gkgday
gkgday
gkgday
respect
day
result
emodin
found
inhibit
replic
cell
cultur
concentr
gml
antivir
index
respect
emodin
treatment
increas
surviv
rate
hsvinfect
mice
prolong
surviv
time
show
higher
efficaci
hsv
elimin
brain
heart
liver
ganglion
compar
viral
control
addit
antivir
activ
emodin
found
equival
acyclovir
vivo
conclus
result
indic
emodin
antihsv
activ
vitro
vivo
thu
promis
agent
clinic
therapi
hsv
infect
herp
simplex
viru
type
common
human
pathogen
famili
herpesvirida
caus
infect
worldwid
estim
human
adult
infect
least
one
bradi
bernstein
either
type
establish
lesion
site
human
bodi
indistinguish
diseas
patel
et
al
hsv
transmit
direct
contact
infect
secret
present
common
biolog
featur
herpesvirus
includ
latenc
reactiv
chakrabarti
et
al
kleymann
greco
et
al
ramachandran
kinchington
clinic
manifest
hsv
infect
vari
asymptomat
infect
mucocutan
lesion
lifethreaten
enceph
fatal
dissemin
depend
portal
viral
entri
host
immun
compet
primari
secondari
natur
diseas
leflor
et
al
nadelman
newcom
bradi
bernstein
date
hsv
infect
incur
may
persist
lifetim
host
result
seri
psychosoci
problem
signific
effort
made
develop
vaccin
agent
hsv
infect
howev
effect
vaccin
current
avail
rajcani
durmanova
us
ramachandran
kinchington
acyclovir
acv
remain
refer
treatment
thirti
year
discoveri
greco
et
al
drugresist
strain
emerg
due
extens
clinic
use
acv
analogu
valacyclovir
penciclovir
famciclovir
although
novel
treatment
avail
uncertainti
efficaci
high
cost
limit
clinic
use
bradi
bernstein
chakrabarti
et
al
kleymann
greco
et
al
kovalchuk
et
al
therefor
remain
continu
need
discov
antivir
agent
hsv
lower
resist
rate
toxic
cost
rhubarb
group
plant
belong
genu
rheum
famili
polygonacea
one
oldest
bestknown
tradit
chines
medicin
chines
rhubarb
includ
rheum
tanguticum
r
tanguticum
rheum
palmatum
rheum
officinal
etc
pharmaceut
relev
compound
rhubarb
sennosid
anthraquinon
stilben
glucos
gallat
naphthalen
catechin
ye
et
al
hsiang
et
al
observ
extract
rhubarb
prevent
process
hsv
attach
penetr
wang
et
al
report
extract
rhubarb
show
antivir
activ
hsv
compar
acyclovir
vivo
number
anthraquinon
anthron
isol
plant
lichen
shown
exhibit
virucid
activ
nonvirucid
antivir
activ
envelop
virus
includ
hsv
meruelo
et
al
schinazi
et
al
tang
et
al
andersen
et
al
sydiski
et
al
barnard
et
al
cohen
et
al
hsiang
et
al
sempl
et
al
anthraquinon
rhubarb
thu
potenti
effect
compon
hsv
anthraquinon
deriv
rhubarb
includ
physcion
emodin
rhein
aloeemodin
chrysophanol
glucosid
ye
et
al
among
emodin
abund
one
huang
et
al
initi
studi
test
emodin
activ
ingredi
r
tanguticum
hsv
infect
investig
antivir
activ
hsv
infect
tissu
cultur
cell
mous
model
human
laryng
carcinoma
cell
routin
grown
medium
hyclon
supplement
heatinactiv
fetal
calf
serum
lglutamin
uml
penicillin
mgml
streptomycin
c
humidifi
atmospher
contain
co
test
medium
use
cytotox
assay
antivir
assay
contain
appropri
serum
overlay
medium
plaqu
assay
consist
medium
plu
fetal
calf
serum
agaros
antibiot
describ
use
studi
stain
stain
virus
propag
cell
viru
titer
estim
cytopath
effect
cpe
induc
viral
infect
express
tissu
cultur
infecti
dosesml
tcid
ml
reedmuench
method
vivo
experi
carri
specificpathogenfre
balbc
mice
week
old
obtain
anim
center
wuhan
univers
viru
titer
inocul
express
median
lethal
dose
ml
titer
isol
viru
express
pfuml
determin
plaqu
assay
anim
research
conduct
accord
intern
accept
principl
guidelin
care
use
laboratori
anim
wuhan
univers
r
tanguticum
cultiv
collect
high
mountain
area
qinghai
china
extract
produc
purifi
depart
plant
chemistri
hubei
colleg
tradit
chines
medicin
hubei
china
fifti
gram
dri
powder
root
r
tanguticum
extract
ethanol
reflux
three
time
h
time
concret
obtain
ethanol
solut
dissolv
ml
h
overnight
solut
mix
ml
ethanol
aceton
vv
ph
follow
ultrason
min
final
product
obtain
filter
dri
main
compon
emodin
quantiti
emodin
observ
determin
high
perform
liquid
chromatographi
hplc
content
emodin
monom
littl
impur
hou
et
al
acyclovir
acv
guanin
synthes
keyi
pharmaceut
co
ltd
hubei
china
cell
seed
cell
per
well
plate
grown
subconflu
remov
growth
medium
cell
incub
variou
concentr
emodin
gml
dissolv
l
test
medium
h
c
humidifi
atmospher
contain
co
cytotox
emodin
evalu
basi
morpholog
chang
cell
microscop
infect
cell
mount
slide
airdri
fix
icecold
methanol
room
temperatur
min
slide
block
bsa
pb
h
c
follow
incub
rabbit
serum
reactiv
hsv
h
c
slide
wash
pb
three
time
incub
fluorescein
isothiocyan
fitc
conjug
goat
immunoglobulin
rabbit
igg
santa
cruz
h
c
result
observ
fluoresc
microscop
cell
preincub
test
medium
contain
differ
concentr
emodin
gml
c
humidifi
atmospher
contain
co
h
h
respect
cell
wash
pb
twice
challeng
tcid
ml
respect
h
incub
viru
adsorpt
cell
rins
twice
pb
incub
test
medium
h
typic
cpe
visibl
inhibit
virusinduc
cpe
score
observ
microscopi
viru
titrat
measur
indirect
assay
four
untreat
viru
control
four
uninfect
cell
control
includ
assay
antivir
index
calcul
use
follow
formula
antivir
index
viral
titer
drug
therapi
group
viral
titer
viral
control
group
data
present
result
experi
perform
triplic
viral
suspens
contain
tcid
ml
viru
incub
equal
volum
medium
contain
differ
concentr
emodin
gml
c
humidifi
atmospher
contain
co
h
h
h
respect
one
hundr
microlit
mix
suspens
ad
subconflu
monolay
cell
h
incub
viru
adsorpt
mix
suspens
remov
cell
monolay
rins
care
pb
maintain
test
medium
c
humidifi
atmospher
contain
co
h
virucid
effect
determin
use
indirect
assay
follow
procedur
describ
experi
carri
state
follow
differ
monolay
subconflu
cell
challeng
tcid
ml
h
cell
wash
pb
overlaid
l
test
medium
contain
differ
concentr
emodin
gml
antivir
effect
determin
use
indirect
assay
follow
procedur
describ
tabl
antivir
effect
emodin
acv
replic
dosag
gml
viral
titer
antivir
index
balbc
mice
infect
intracerebr
l
viral
suspens
contain
ld
ml
mice
infect
viru
randomli
divid
group
emodin
dose
gkgday
acyclovir
dose
gkgday
oral
administ
three
time
daili
mice
h
interv
day
begin
h
postviru
exposur
placebo
control
receiv
sodium
chlorid
viru
control
normal
control
without
viral
infect
receiv
treatment
mice
observ
daili
day
infect
blood
organ
collect
viru
isol
detect
group
day
infect
three
mice
per
group
tissu
sampl
homogen
wv
suspens
test
medium
sera
isol
blood
sampl
centrifug
homogen
sera
inocul
monolay
cell
plate
quadrupl
c
humidifi
atmospher
contain
co
viru
antigen
detect
indirect
assay
cpe
observ
titer
isol
viru
determin
plaqu
assay
serial
dilut
viral
supernat
mixtur
posit
well
inocul
monolay
cell
plate
quadrupl
excess
viru
medium
remov
h
incub
replac
overlay
medium
contain
agaros
agaros
overlay
remov
incub
h
cell
fix
formalin
stain
crystal
violet
plaqu
count
viral
titer
determin
data
analyz
spss
softwar
data
vitro
experi
analyz
use
student
ttest
vivo
experi
analyz
use
wilcoxon
test
surviv
rate
analysi
varianc
anova
mean
time
death
mtd
kaplanmei
method
surviv
analysi
cytotoxicit
emodin
cell
evalu
subconflu
monolay
treat
emodin
concentr
gml
show
visibl
chang
cell
morpholog
cell
densiti
cell
treat
emodin
concentr
gml
gml
grew
tardili
show
alter
cell
morpholog
cell
treat
emodin
subsequ
infect
describ
section
emodin
concentr
gml
show
inhibitori
activ
titer
antivir
index
signific
differ
group
p
indic
emodin
abl
block
viral
adsorpt
cell
investig
direct
inactiv
effect
emodin
virus
treat
h
h
h
concentr
emodin
rang
gml
respect
virucid
effect
emodin
observ
mix
suspens
could
still
infect
cell
propag
infect
titer
suspens
influenc
either
interact
time
dose
emodin
titer
antivir
index
emodintr
group
signific
differ
emodintr
group
untreat
viru
control
group
p
indic
emodin
abl
directli
inactiv
virus
show
virucid
effect
subconflu
cell
infect
viru
incub
drug
describ
section
shown
tabl
effect
dose
emodin
start
gml
gml
viru
titer
dosag
decreas
compar
viru
control
group
p
antivir
effect
enhanc
correspondingli
increas
dosag
antivir
index
emodin
time
concentr
reach
gml
antivir
activ
emodin
stronger
dosag
accord
antivir
index
antivir
effect
emodin
acv
equival
concentr
gml
regard
antivir
index
p
sign
viral
infect
observ
mice
day
inocul
weightloss
tendenc
huddl
ruffl
fur
paralysi
limb
spasm
diminish
vital
clinic
manifest
show
differ
mice
infect
howev
infect
mice
show
differ
experiment
group
gkgday
emodin
group
show
prolong
mtd
compar
gkgday
gkgday
group
p
gkgday
emodin
group
show
favor
surviv
rate
hsv
subtyp
infect
mice
longer
mtd
infect
mice
compar
acv
treatment
group
p
day
delay
onset
diseas
compar
infect
mice
shown
fig
mice
viru
control
group
n
mice
placebo
control
group
n
die
within
day
diseas
surviv
rate
increas
mtd
prolong
treatment
group
infect
mice
gkgday
emodin
group
show
better
surviv
rate
prolong
mtd
day
compar
gkgday
day
gkgday
day
group
p
toxic
appear
dosag
reach
gkgday
gkgday
emodin
group
show
favor
surviv
rate
hsv
subtyp
infect
mice
longer
mtd
infect
mice
day
compar
acv
treatment
group
p
viral
antigen
organ
infect
mice
brain
heart
liver
ganglion
detect
indirect
assay
viral
antigen
posit
organ
earli
stage
infect
within
week
infect
viral
antigen
disappear
differ
length
time
correspond
variou
dosag
treatment
medicin
tabl
chang
viru
titer
brain
heart
liver
ganglion
infect
mice
differ
group
shown
fig
administr
emodin
gkgday
gkgday
group
significantli
reduc
viru
titer
mice
organ
homogen
compar
nacl
control
group
p
time
need
viru
elimin
dosedepend
viru
titer
brain
heart
liver
emodin
group
began
decreas
day
treatment
day
infect
reduct
viru
titer
ganglion
observ
delay
compar
organ
gkgday
gkgday
emodin
group
show
faster
viru
elimin
gkgday
group
p
result
suggest
emodin
effect
treatment
hsv
infect
current
studi
demonstr
antivir
activ
emodin
extract
r
tanguticum
vitro
vivo
vitro
emodin
could
prevent
cell
hsv
infect
pretreat
assay
could
show
virucid
effect
howev
present
antivir
activ
hsv
infect
result
reveal
antivir
activ
emodin
potent
howev
decreas
cpe
viral
titer
cultur
media
dosedepend
hsv
type
equival
antivir
activ
acv
hsv
type
result
impli
emodin
may
inhibit
hsv
biolog
synthesi
rather
directli
inactiv
virus
block
absorpt
suscept
cell
vitro
employ
hsvinfect
balbc
mice
mous
model
use
screen
evalu
antihsv
agent
emodintr
mice
show
better
surviv
rate
prolong
mtd
decreas
viral
titer
faster
elimin
viru
tissu
compar
viru
control
group
effect
dose
gkgday
equival
acv
dose
gkgday
mice
die
gkgday
emodin
group
day
due
remnant
viru
exist
organ
brain
ganglion
heart
liver
hsiang
ho
found
emodin
specif
inhibit
ul
activ
viral
protein
involv
viral
dna
process
capsid
egress
exert
antivir
activ
accumul
nucleocapsid
nucleu
reduc
yield
explain
emodin
decreas
hsv
replic
experi
sever
studi
demonstr
emodin
inhibit
casein
kinas
involv
phosphoryl
mani
viral
protein
essenti
life
cycl
yim
et
al
battistutta
et
al
potent
antivir
capac
emodin
could
also
base
abil
disrupt
lipid
bilay
result
effect
inactiv
envelop
viru
alv
et
al
infect
current
common
caus
genit
ulcer
diseas
one
risk
factor
human
immunodefici
viru
hiv
acquisit
anuradha
et
al
studi
shown
hivinfect
patient
signific
seropreval
chen
et
al
mbopik
et
al
mostad
et
al
anuradha
et
al
latter
alter
host
immun
sheth
et
al
facilit
hiv
transmiss
acquisit
celum
antihsv
therapi
therefor
evalu
strategi
hiv
prevent
celum
et
al
may
benefit
hivinfect
fig
effect
emodin
viral
titer
chang
hsvinfect
mice
viral
titer
brain
infect
mice
b
viral
titer
heart
infect
mice
c
viral
titer
liver
infect
mice
viral
titer
ganglion
infect
mice
e
viral
titer
brain
infect
mice
f
viral
titer
heart
infect
mice
g
viral
titer
liver
infect
mice
h
viral
titer
ganglion
infect
mice
mice
infect
describ
section
mice
treat
differ
dose
emodin
gkgday
nacl
control
day
begin
h
infect
viral
titer
repres
geometr
mean
sd
per
organ
mice
group
gkgday
gkgday
emodin
group
start
show
significantli
reduc
viru
titer
mice
organ
homogen
day
infect
compar
nacl
group
p
patient
well
aburaddad
et
al
mayaud
et
al
studi
emodin
show
potent
activ
vitro
vivo
may
serv
promis
agent
combat
simultan
prevent
high
risk
popul
acquir
hiv
summari
result
indic
emodin
effect
antivir
agent
infect
observ
potent
inhibit
studi
also
demonstr
antivir
activ
emodin
envelop
virus
hepat
b
viru
human
cytomegaloviru
sever
acut
respiratori
syndromecorona
viru
nonenvelop
virus
polioviru
barnard
et
al
cohen
et
al
sempl
et
al
shuangsuo
et
al
ho
et
al
hsiang
ho
consid
find
emodin
may
potenti
play
signific
role
antihsv
manag
broad
spectrum
antivir
activ
